Paul R Edick Insider Trading $PDLI PDL BIOPHARMA, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Paul R Edick.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Paul R Edick. Paul R Edick is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in NEWLINK GENETICS CORP ($NLNK) and See Remarks in XERIS PHARMACEUTICALS INC ($XERS) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in Milestone Pharmaceuticals Inc. ($MIST) and Director in Neos Therapeutics, Inc. ($NEOS) and Director in Iterum Therapeutics plc ($ITRM).

Paul R Edick in PDL BIOPHARMA, INC.

Trading Symbol: PDLI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul R Edick: Director
Holdings: 214,563 shares
Current Value: $474,184
Latest Transaction: Jun 12 2018
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Paul R Edick in PDL BIOPHARMA, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ITRM, NLNK, MIST, NEOS, PDLI, SCMP, XERS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 12 2018	PDLI	PDL BIOPHARMA, INC ...	Edick Paul R	Director	Grant	A	2.76	54,348	150,000	214,563	160.2 K to 214.6 K (+33.92 %)
Jun 12 2017	PDLI	PDL BIOPHARMA, INC ...	Edick Paul R	Director	Grant	A	2.47	60,729	150,001	160,215	99.5 K to 160.2 K (+61.04 %)
Jun 03 2016	PDLI	PDL BIOPHARMA, INC ...	Edick Paul R	Director	Grant	A	3.52	71,023	250,001	99,486	28.5 K to 99.5 K (+249.53 %)
Sep 08 2015	PDLI	PDL BIOPHARMA, INC ...	Edick Paul R	Director	Grant	A	5.27	28,463	150,000	28,463	0 to 28.5 K

Page: 1